SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,867.94 |
| Enterprise Value ($M) | 4,317.41 |
| Book Value ($M) | 1,577.61 |
| Book Value / Share | 31.38 |
| Price / Book | 1.82 |
| NCAV ($M) | -1,799.80 |
| NCAV / Share | -35.80 |
| Price / NCAV | -1.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.06 |
| Return on Equity (ROE) | 0.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.21 |
| Current Ratio | 2.04 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 293.27 |
| Assets | 3,670.68 |
| Liabilities | 2,093.07 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1,086.81 |
| Operating Income | 336.61 |
| Net Income | 205.38 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 259.92 |
| Cash from Investing | -256.51 |
| Cash from Financing | -7.57 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 10.98 | 2.38 | |
| 13G/A | Dimensional Fund Advisors Lp | 6.90 | -0.50 | |
| 13G/A | BlackRock Inc. | 16.20 | 29.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 27,789 | 192,260 | 14.45 | |
| 19,017 | 165,610 | 11.48 | |
| 63,276 | 354,532 | 17.85 | |
| 38,586 | 293,556 | 13.14 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| NVO – Novo-Nordisk A/S | NVS – Novartis AG |
| OGN – Organon & Co. | PFE – Pfizer Inc. |
| PRGO – Perrigo Company PLC |
Financial data and stock pages provided by
Fintel.io